Facial Palsy Treatment

The Primary objective of the study is to investigate the most effective treatment modalities available to speech language pathologist as well as movement difference by comparing them.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Facial Palsy Facial Paralysis Mouth Diseases Nervous System Diseases Neurologic Manifestations Paralysis Pathological Conditions, Signs and Symptoms Signs and Symptoms Stomatognathic Diseases Stroke Rehabilitation

Age range

20 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hamad Medical Corporation

Doha, Qatar, 3050

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with 1st stroke
Hemorrhagic stroke
Ischemic stroke
Right hemispheric stroke
Left hemispheric stroke
Normal cognitive skills (Based on Montreal cognitive assessment MOCA)
Normal Language (Not Aphasic)
Normal swallowing

Exclusion criteria

Patients with Bell's palsy
Facial trauma
Post otitis media surgeries
Neoplasm, malignant or tumor cell invasion of facial nerve
Cognitive impairment
Patients with aphasia
Patients on defibrillator cardiac devices
Patients with pacemakers or any other type of cardiac devices
Multiple strokes

Treatment and study plan

Neuro muscular electrical stimulation

Other

electrical stimulation to facial nerve to improve facial palsy

Beckmann's oral motor exercises

Other

Oral motor exercises to improve facial palsy.

Primary outcomes

Sunnybrook Facial Grading System

Time frame: Patients were enrolled for 30sessions as per the protocol. Participants were given 5 sessions in a week. Patients were assessed as baseline upon enrollment into the study and re-assessed beginning of each week.

Upon enrollment Sunnybrook is given as baseline. The minimum score a patient may score is 20 out of 100. The higher the score the better (means patient has minor facial asymmetry). Each participant/patient was planned for 30sessions. Baseline score was recorded and beginning of each week Sunnybrook was given and new score was recorded by the same clinician.

Sponsors and collaborators

Lead sponsor

Hamad Medical Corporation

Industry

Registry information

Official study title

Facial Palsy Treatment: Investigating the Most Effective Modality of Therapy for Recovery?

Acronym: NMES

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: May 16, 2025
Registry last updated: May 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed